RYCFX
Rydex Biotechnology Fund - C Class
$55.00
Rydex Biotechnology Fund - C Class (RYCFX)
The Rydex Biotechnology Fund (RYCFX) is a mutual fund that focuses on investing in companies within the biotechnology industry. This fund is classified as a C Class fund, which typically indicates a higher expense ratio and potentially higher returns. RYCFX aims to provide investors with exposure to the rapidly growing biotechnology sector, which includes companies involved in the development and commercialization of innovative medical treatments and technologies. This fund may be suitable for investors seeking long-term growth potential and are comfortable with higher risk investments.
RYCFX Mutual Fund Chart & Stats
$55.00
At close: 4:00 PM EST- Previous Close
- $55.00
- Sub-Category
- Sector-Specific
- Total Liabilities
- $1.09M
- Expense Ratio
- 2.38%
- Holding Count
- 70
- Brand
- Rydex Series Funds
- Category
- Equity
- Total Assets
- 137.90M
- Shares Outstanding
- N/A
- 52-Week Range
- $41.36 - $57.37
RYCFX Mutual Fund News
RYCFX Mutual Fund Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| ABBVAbbvie | 8.17% |
| AMGNAmgen Inc | 5.05% |
| GILDGilead Sciences | 4.49% |
| VRTXVertex Pharmaceuticals Inc. | 4.32% |
| REGNRegeneron Pharmaceuticals | 2.93% |
| RVMDRevolution Medicines, Inc. | 2.48% |
| ALNYAlnylam Pharmaceuticals | 2.36% |
| ONCBeOne Medicines | 2.17% |
| MRNAModerna | 2.15% |
| BIIBBiogen Inc. | 2.13% |
| Total | 36.24% |
Recently Viewed
No data currently available






